Dual-modality fluorescence lifetime imaging-optical coherence tomography intravascular catheter system with freeform catheter optics.


Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
07 2022
Historique:
received: 17 05 2022
accepted: 27 06 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 26 7 2022
Statut: ppublish

Résumé

Intravascular imaging is key to investigations into atherosclerotic plaque pathobiology and cardiovascular diagnostics overall. The development of multimodal imaging devices compatible with intracoronary applications has the potential to address limitations of currently available single-modality systems. We designed and characterized a robust, high performance multimodal imaging system that combines optical coherence tomography (OCT) and multispectral fluorescence lifetime imaging (FLIm) for intraluminal simultaneous assessment of structural and biochemical properties of coronary arteries. Several shortcomings of existing FLIm-OCT catheter systems are addressed by adopting key features, namely (1) a custom fiber optic rotary joint based on an air bearing, (2) a broadband catheter using a freeform reflective optics, and (3) integrated solid-state FLIm detectors. Improvements are quantified using a combination of experimental characterization and simulations. Excellent UV and IR coupling efficiencies and stability (IR: 75.7 % ± 0.4 % , UV: 45.7 % ± 0.35 % ) are achieved; high FLIm optical performance is obtained (UV beam FWHM: 50 μm) contemporaneously with excellent OCT beam quality (IR beam FWHM: 17 μm). High-quality FLIm OCT image of a human coronary artery specimen was acquired. The ability of this intravascular imaging system to provide comprehensive structural and biochemical properties will be valuable to further our understanding of plaque pathophysiology and improve cardiovascular diagnostics.

Identifiants

pubmed: 35864574
pii: JBO-220103GR
doi: 10.1117/1.JBO.27.7.076005
pmc: PMC9300477
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB015903
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB032840
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL157712
Pays : United States

Références

Opt Express. 2021 Jun 21;29(13):20105-20120
pubmed: 34266107
Opt Lett. 2017 Dec 1;42(23):4978-4981
pubmed: 29216160
Sci Rep. 2017 Aug 21;7(1):8960
pubmed: 28827758
Light Sci Appl. 2020 Jul 20;9:124
pubmed: 32704357
Atherosclerosis. 2012 Feb;220(2):394-401
pubmed: 22138141
Opt Lett. 2017 Oct 1;42(19):3753-3756
pubmed: 28957119
J Biomed Opt. 2014 Jun;19(6):066004
pubmed: 24898604
J Biomed Opt. 2020 Sep;25(9):
pubmed: 33000570
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Biomed Opt Express. 2018 Aug 06;9(9):4064-4076
pubmed: 30615748
Opt Express. 2013 Aug 12;21(16):19280-91
pubmed: 23938845
JACC Cardiovasc Imaging. 2021 Sep;14(9):1832-1842
pubmed: 33221238
Int J Cardiovasc Imaging. 2015 Feb;31(2):259-68
pubmed: 25341407
Sci Rep. 2018 Sep 28;8(1):14561
pubmed: 30267024
Phys Med Biol. 2012 Feb 21;57(4):843-65
pubmed: 22290334
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Eur Heart J. 2017 Feb 7;38(6):400-412
pubmed: 27118197
J Biophotonics. 2021 Oct;14(10):e202100048
pubmed: 34164943
J Biomed Opt. 2010 Nov-Dec;15(6):067006
pubmed: 21198210
Eur Heart J. 2018 Nov 1;39(41):3685-3686
pubmed: 30383273
Sci Rep. 2020 Feb 18;10(1):2863
pubmed: 32071412
Opt Express. 2010 Nov 22;18(24):24395-404
pubmed: 21164786
Opt Lett. 2019 Oct 15;44(20):4961-4964
pubmed: 31613239
Opt Lett. 2016 May 1;41(9):1973-6
pubmed: 27128052
Front Cardiovasc Med. 2020 Nov 23;7:587100
pubmed: 33330648
Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):613-620
pubmed: 28329320
J Biomed Opt. 2020 May;25(7):1-43
pubmed: 32406215

Auteurs

Cai Li (C)

University of California, Department of Biomedical Engineering, Davis, California, United States, United States.

Julien Bec (J)

University of California, Department of Biomedical Engineering, Davis, California, United States, United States.

Xiangnan Zhou (X)

University of California, Department of Biomedical Engineering, Davis, California, United States, United States.

Laura Marcu (L)

University of California, Department of Biomedical Engineering, Davis, California, United States, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH